01 12ABX Advanced Biochemical Compounds
02 1GE Healthcare Inc
03 1HUAYI ISOTOPE CO
04 2Rotem Industries
01 1China
02 12Germany
03 2Israel
04 1United Kingdom
01 3Active
02 1Inactive
03 12Blank
01 2Valid
02 14Blank
01 16Blank
01 16Blank
01 16Blank
01 161704-001
02 171934-0001
03 171934-0003
04 171934-0004
05 171934-0005
06 171934-0006
07 171934-0007
08 171934-0008
09 171934-0009
10 171934-0010
11 171934-0011
12 171934-0028
13 171934-0029
14 3Blank
01 16Blank
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36900
Submission : 2022-04-01
Status : Active
Type : II
Certificate Number : CEP 2022-176 - Rev 01
Issue Date : 2026-04-23
Type : Chemical
Substance Number : 2294
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22823
Submission : 2009-05-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21089
Submission : 2007-11-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21130
Submission : 2007-12-07
Status : Inactive
Type : II
Certificate Number : CEP 2011-287 - Rev 03
Issue Date : 2025-01-14
Type : Chemical
Substance Number : 2294
Status : Valid
NDC Package Code : 61704-001
Start Marketing Date : 2014-01-14
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1mg/mg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71934-0004
Start Marketing Date : 2020-02-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (20mg/20mg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71934-0005
Start Marketing Date : 2020-02-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25mg/25mg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71934-0006
Start Marketing Date : 2020-02-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100mg/100mg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71934-0007
Start Marketing Date : 2020-02-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1000mg/1000mg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71934-0008
Start Marketing Date : 2020-02-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25mg/25mg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71934-0009
Start Marketing Date : 2020-02-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25mg/25mg)
Marketing Category : BULK INGREDIENT
42
PharmaCompass offers a list of TATM API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right TATM manufacturer or TATM supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred TATM manufacturer or TATM supplier.
A Mannose triflate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mannose triflate, including repackagers and relabelers. The FDA regulates Mannose triflate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mannose triflate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mannose triflate supplier is an individual or a company that provides Mannose triflate active pharmaceutical ingredient (API) or Mannose triflate finished formulations upon request. The Mannose triflate suppliers may include Mannose triflate API manufacturers, exporters, distributors and traders.
click here to find a list of Mannose triflate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
We have 4 companies offering Mannose triflate
Get in contact with the supplier of your choice:
